Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Viridian Therapeutics Inc (VRDN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | 0 | 0.00 | Sell 100.00% | 0.64 | SEC | ||
| 2025 Q3 | 2,212,701 | 0.64 | Reduce 1.96% | <0.01 | $21.58 | $47,750,088 | SEC |
| 2025 Q2 | 2,257,010 | 0.48 | Add 9.50% | 0.04 | $13.98 | $31,553,000 | SEC |
| 2025 Q1 | 2,061,274 | 0.50 | Add 0.36% | <0.01 | $13.48 | $27,785,974 | SEC |
| 2024 Q4 | 2,053,906 | 0.71 | Add 2.84% | 0.02 | $19.17 | $39,373,378 | SEC |
| 2024 Q3 | 1,997,153 | 0.89 | Reduce 39.63% | 0.32 | $22.75 | $45,435,231 | SEC |
| 2024 Q2 | 3,307,945 | 0.82 | Add 22.86% | 0.15 | $13.01 | $43,036,364 | SEC |
| 2024 Q1 | 2,692,414 | 0.88 | Add 15.76% | 0.12 | $17.51 | $47,144,169 | SEC |
| 2023 Q4 | 2,325,841 | 1.01 | Buy | 1.01 | $21.78 | $50,656,817 | SEC |